官方服务：
资源简介：
Order-aware deep learning for drug combination benefit prediction in cancer cell lines
应用场景：
提供机构：
Xuan Liu相关数据集
SCAtlas HCL：人类癌症细胞系数据库
SCAtlas HCL数据库分析了40个人类癌症细胞系和2个人类正常细胞系的23,089个细胞，构建单细胞转组图谱并实现数据可视化，深入探索了各个癌症细胞系内的转录组和表观遗传异质性，发现转录组异质性是不同癌症的共同特征，并揭示了转录组和表观基因组之间相互作用的分子机制源。 发布于 2023-12-09 Zhu, Q., Zhao, X., Zhang, Y. e
CNGBdb2025-03-20 更新220
Additional file 3 of Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Additional file 3. Tables S1-S8.
NIAID Data Ecosystem30
Fourteen highly predictive synergistic drug combinations in oncology-screen supported by literature.
Fourteen highly predictive synergistic drug combinations in oncology-screen supported by literature.
NIAID Data Ecosystem20
SynGeNet: Synergy from gene expression and network mining
SynGeNet R package implements a drug combination prediction method based on user-provided disease network data, drug target data and drug gene expression data. Users have the option to provide the
DataCite Commons2020-08-27 更新70
Epigenetic subtypes of neuroblastoma [cell lines]
In the absence of recurrent gene mutations, evidence accumulates that epigenetic deregulation plays a prominent role in neuroblastoma biology. Here we provide genome wide H3K27ac profiles in 25 neurob
NIAID Data Ecosystem20
